` ORCHPHARMA (Orchid Pharma Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

ORCHPHARMA
vs
BSE Sensex 30

Over the past 12 months, ORCHPHARMA has underperformed BSE Sensex 30, delivering a return of -30% compared to the BSE Sensex 30's 5% growth.

Stocks Performance
ORCHPHARMA vs BSE Sensex 30

Loading

Performance Gap
ORCHPHARMA vs BSE Sensex 30

Loading
ORCHPHARMA
BSE Sensex 30
Difference

Performance By Year
ORCHPHARMA vs BSE Sensex 30

Loading
ORCHPHARMA
BSE Sensex 30
Add Stock

Competitors Performance
Orchid Pharma Ltd vs Peers

BSE Sensex 30
ORCHPHARMA
LLY
JNJ
NOVO B
ROG
Add Stock

Orchid Pharma Ltd
Glance View

Market Cap
39.4B INR
Industry
Pharmaceuticals

Orchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company is headquartered in Chennai, Tamil Nadu. The firm is involved in the development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals. The company has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. The company offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

ORCHPHARMA Intrinsic Value
1 177.64 INR
Undervaluation 34%
Intrinsic Value
Price
Back to Top